JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M403689200 on August 13, 2004

J. Biol. Chem., Vol. 279, Issue 43, 44563-44572, October 22, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/43/44563    most recent
M403689200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Qu, Z.
Right arrow Articles by Xiao, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Qu, Z.
Right arrow Articles by Xiao, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Tax Deregulation of NF-{kappa}B2 p100 Processing Involves Both {beta}-TrCP-dependent and -independent Mechanisms*

Zhaoxia Qu{ddagger}, Guoliang Qing{ddagger}, Arnold Rabson§, and Gutian Xiao{ddagger}

From the {ddagger}Department of Cell Biology and Neuroscience, Rutgers, The State University of New Jersey, Piscataway, New Jersey 08854, and §Center for Advanced Biotechnology and Medicine (CABM), and Cancer Institute of New Jersey, Department of Molecular Genetics, Microbiology and Immunology, The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway, New Jersey 08855

Processing of the nf-{kappa}b2 gene product p100 to generate p52 is a tightly regulated event, consistent with the fact that the processing product, p52, is hardly detected in most cell types, including T cells, although the precursor p100 is expressed abundantly in these cells. However, in T cells transformed by the human T-cell leukemia virus type I (HTLV-I), p100 processing is very active, resulting in high level expression of p52. Because overproduction of p52 is associated with lymphoid hyperplasia and transformation, deregulation of p100 processing may be part of the oncogenic mechanism of HTLV-I. We demonstrated previously that HTLV-I Tax oncoprotein is a potent inducer of p100 processing through specific targeting of IKK{alpha} via IKK{gamma} to p100 to trigger p100 phosphorylation and ubiquitination. In this study, we further show that Tax-mediated recruitment of IKK{alpha} to p100 requires serines 866 and 870 of p100, shown to be essential for inducible processing of p100. Upon interaction with p100, activated IKK{alpha} phosphorylates both N- and C-terminal serines of p100 (serines 99, 108, 115, 123 and 872), serving as a critical step in Tax-induced p100 processing. Using a genetic approach, we find that {beta}-transducin repeat-containing protein, a component of the SCF ubiquitin ligase complex, previously shown to be required for physiological p100 processing mediated by nuclear factor-{kappa}B-inducing kinase, is only partially involved in Tax-induced processing of p100. These results indicate that both {beta}-transducin repeat-containing protein-dependent and -independent mechanisms contribute to Tax-deregulated p100 processing, further suggesting the involvement of different mechanisms in cellular and viral pathways of p100 processing.


Received for publication, April 2, 2004 , and in revised form, July 1, 2004.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: Nelson Biological Laboratories, Rutgers, The State University of New Jersey, 604 Allison Rd., Piscataway, NJ 08854. Tel.: 732-445-2839; Fax: 732-445-5870; E-mail: xiao{at}biology.rutgers.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Qing, Z. Qu, and G. Xiao
Endoproteolytic processing of C-terminally truncated NF-{kappa}B2 precursors at {kappa}B-containing promoters
PNAS, March 27, 2007; 104(13): 5324 - 5329.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
M. Barry and K. Fruh
Viral Modulators of Cullin RING Ubiquitin Ligases: Culling the Host Defense
Sci. Signal., May 16, 2006; 2006(335): pe21 - pe21.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Qing, Z. Qu, and G. Xiao
Stabilization of Basally Translated NF-{kappa}B-inducing Kinase (NIK) Protein Functions as a Molecular Switch of Processing of NF-{kappa}B2 p100
J. Biol. Chem., December 9, 2005; 280(49): 40578 - 40582.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Qing and G. Xiao
Essential Role of I{kappa}B Kinase {alpha} in the Constitutive Processing of NF-{kappa}B2 p100
J. Biol. Chem., March 18, 2005; 280(11): 9765 - 9768.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Qing, Z. Qu, and G. Xiao
Regulation of NF-{kappa}B2 p100 Processing by Its cis-Acting Domain
J. Biol. Chem., January 7, 2005; 280(1): 18 - 27.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.